CNSX:ISOL - 1mage Software Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New 1mage Software Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ISOL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ISOL

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
This price target is based on 0 analysts offering 12 month price targets for 1mage Software in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.

N/A

The current consensus among 0 contributing investment analysts is to n/a stock in 1mage Software. This rating has held steady since September 2019, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/22/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/17/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/16/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/16/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/14/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/3/2018Fundamental ResearchReiterated RatingBuy ➝ Buy$10.10 ➝ $10.10
i
9/5/2018Fundamental ResearchSet Price TargetBuy$10.10
i
8/17/2018Fundamental ResearchLower Price TargetTop Pick ➝ Top Pick$25.10 ➝ $10.10
i
4/13/2018Fundamental ResearchSet Price TargetBuy$2.51
i
3/29/2018Fundamental ResearchSet Price TargetTop Pick ➝ Buy$2.59 ➝ $2.51
i
1/10/2018Fundamental ResearchSet Price TargetBuy$2.59
i
12/28/2017Fundamental ResearchSet Price TargetBuy$2.59
i
12/21/2017Fundamental ResearchInitiated CoverageTop Pick$2.59
i
(Data available from 6/14/2016 forward)
1mage Software logo
Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.
Read More

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

159,134 shs

Average Volume

164,946 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of 1mage Software?

The following Wall Street sell-side analysts have issued stock ratings on 1mage Software in the last twelve months:
View the latest analyst ratings for ISOL.

What is the current price target for 1mage Software?

0 Wall Street analysts have set twelve-month price targets for 1mage Software in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for 1mage Software in the next year.
View the latest price targets for ISOL.

What is the current consensus analyst rating for 1mage Software?

1mage Software currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for ISOL.

What other companies compete with 1mage Software?

How do I contact 1mage Software's investor relations team?

The company's listed phone number is 800-844-1468. The official website for 1mage Software is www.1mage.com.